Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
calcipotriol + salicylic acid
- Development stage
- Unknown
- Lead developer
- LEO Pharma
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
A combination topical treatment for psoriasis that combines calcipotriol (a vitamin D analog) with salicylic acid (a keratolytic agent). Calcipotriol helps normalize skin cell growth and reduce inflammation, while salicylic acid helps remove scales and enhances medication penetration. This combination has shown effectiveness in treating psoriasis of the hands, feet, and nails.
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on calcipotriol + salicylic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on calcipotriol + salicylic acid.